Xizang Haisco Pharmaceutical Group Co Ltd (002653) — Financial Flexibility Index
Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥112.14 Million (operating CF CN¥39.68 Million minus capex CN¥72.46 Million) represents 0% of total liabilities (CN¥2.99 Billion). Check 002653 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Xizang Haisco Pharmaceutical Group Co Ltd Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Xizang Haisco Pharmaceutical Group Co Ltd across 18 annual periods. See working capital position of Xizang Haisco Pharmaceutical Group Co Lt to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
Year-by-year free cash flow to debt coverage for Xizang Haisco Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see market cap of Xizang Haisco Pharmaceutical Group Co Lt.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.41x | CN¥1.12 Billion | CN¥786.00 Million | CN¥2.72 Billion | ▲ +20.8% |
| 2024 | 0.34x | CN¥882.70 Million | CN¥442.05 Million | CN¥2.60 Billion | ▲ +0.4% |
| 2023 | 0.34x | CN¥840.59 Million | CN¥449.58 Million | CN¥2.48 Billion | ▲ +24.2% |
| 2022 | 0.27x | CN¥794.71 Million | CN¥94.55 Million | CN¥2.91 Billion | ▼ -23.0% |
| 2021 | 0.35x | CN¥738.74 Million | CN¥35.80 Million | CN¥2.09 Billion | ▼ -5.9% |
| 2020 | 0.38x | CN¥807.93 Million | CN¥206.21 Million | CN¥2.15 Billion | ▼ -25.7% |
| 2019 | 0.51x | CN¥1.35 Billion | CN¥764.26 Million | CN¥2.66 Billion | ▲ +45.7% |
| 2018 | 0.35x | CN¥824.59 Million | CN¥472.61 Million | CN¥2.37 Billion | ▼ -5.3% |
| 2017 | 0.37x | CN¥785.07 Million | CN¥391.81 Million | CN¥2.14 Billion | ▼ -10.9% |
| 2016 | 0.41x | CN¥617.44 Million | CN¥409.20 Million | CN¥1.50 Billion | ▼ -39.3% |
| 2015 | 0.68x | CN¥726.70 Million | CN¥443.03 Million | CN¥1.07 Billion | ▼ -29.4% |
| 2014 | 0.96x | CN¥737.43 Million | CN¥502.57 Million | CN¥767.55 Million | ▼ -30.4% |
| 2013 | 1.38x | CN¥732.40 Million | CN¥568.41 Million | CN¥530.24 Million | ▼ -44.2% |
| 2012 | 2.47x | CN¥590.05 Million | CN¥464.75 Million | CN¥238.49 Million | ▼ -24.9% |
| 2011 | 3.29x | CN¥378.52 Million | CN¥260.79 Million | CN¥114.95 Million | ▲ +29.9% |
| 2010 | 2.54x | CN¥448.33 Million | CN¥367.38 Million | CN¥176.79 Million | ▲ +38.5% |
| 2009 | 1.83x | CN¥392.22 Million | CN¥368.21 Million | CN¥214.22 Million | ▲ +92.7% |
| 2008 | 0.95x | CN¥131.82 Million | CN¥94.45 Million | CN¥138.73 Million | — |